American Funds The Growth Fund of America® Class 529-A (CGFAX) kopieguldījumu fonda cena un jaunumi

SākumlapaCGFAX • Ieguldījumu fonds

American Funds The Growth Fund of America® Class 529-A

77,91 $

26. febr. · USD · MUTF · Atruna

American Funds The Growth Fund of America® Class 529-C

66,46 $

CGFCX0,43%

American Funds The Growth Fund of America® Class A

79,46 $

AGTHX0,43%

American Funds The Growth Fund of America® Class 529-E

76,30 $

CGFEX0,43%

American Funds The Growth Fund of America® Class 529-F

77,58 $

CGFFX0,42%

American Funds The Growth Fund of America® Class R-6

79,61 $

RGAGX0,43%

American Funds The Growth Fund of America® Class R-4

78,34 $

RGAEX0,43%

American Funds The Growth Fund of America® Class F-1

78,63 $

GFAFX0,42%

American Funds The Growth Fund of America® Class R-1

68,20 $

RGAAX0,42%

American Funds The Growth Fund of America® Class R-3

76,45 $

RGACX0,43%

American Funds The Growth Fund of America® Class R-5

79,45 $

RGAFX0,43%

Ieguldījumu fonds

Slēgšanas kurss

78,24 $

Peļņa no gada sākuma

0,60%

Izdevumu koeficients

0,62%

Kategorija

US Equity Large Cap Growth

Morningstar vērtējums

Neto aktīvi

17,11 mljrd. USD

Peļņa

0,25%

Komisija

3,50%

Ieviešanas datums

2002. gada 15. febr.

Tirgus ziņas

Quiver Quantitative

pirms 32 minūtēm

XTL Biopharmaceuticals Limited Faces Nasdaq Delisting Following Insolvency of Subsidiary The Social Proxy

FreeCast Inc. (Nasdaq: CAST) Announces Rescheduling of Direct Listing to March 10, 2026

Intellia Therapeutics

pirms 1 dienas

Intellia Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Business Updates

In early trading, the Dow Jones Industrial Average plunged over 700 points while Netflix surged 10% following its decision to abandon an acquisition.

SPAC Miluna (NASDAQ: MMTX) appoints independent director Yajuan Ding

Generate Biomedicines shares fall in weak Nasdaq debut for drug developer